Search
cteh logo
  • Emergency
  • 1.866.869.2834
  • Blog
  • close select your language
  • About
    Back
    • About
    • About Us
    • Senior Leadership
    • Key Personnel
    • Publications
  • Solutions
    Back
    • Solutions
    • Readiness
    • Response
    • Recovery
  • Services
    Back
    • Services
    • Disaster Recovery
    • Emergency Response
    • Environmental Response
    • Epidemiology
    • Expert Services
    • Industrial Hygiene
    • Occupational Health
    • Pandemic Services
    • Response Management
    • Risk Assessment
    • Safety
    • Technology
    • Toxicology
    • Training
  • Markets
    Back
    • Markets
    • Chemicals
    • Government & Public Sector
    • Manufacturing
    • Maritime
    • Petroleum
    • Pipeline
    • Power and Utilities
    • Transportation
  • Software
    Back
    • Software
    • CarbonCM
    • Carbon Stories
  • Careers
    Back
    • Careers
    • Opportunities
  • Media
    Back
    • Media
    • Case Studies
    • FAQ
    • Inside CTEH Blog
  • Contact
    Back
    • Contact
    • Contact Us

2023 CTEH. All Rights Reserved.

Back

John Lipscomb, PhD, DABT, FATS

Senior Toxicologist

John Lipscomb is a senior toxicologist for CTEH®, LLC. His scientific career began in 1984 at the bench as a Principal Investigator at the National Center for Toxicological Research (U.S. FDA, Jefferson, AR). There, he completed research requirements for his Master’s and Doctorate degrees by performing experiments to characterize the adult and transplacental pharmacokinetics of trimethyltin, a potent neurotoxicant. Later his studies expanded to include mechanistic and enzyme inhibition. In 1991, Dr. Lipscomb began active duty service in the U.S. Air Force, posted at Wright-Patterson AFB in Dayton, Ohio. Dr. Lipscomb supported investigations into the pharmacokinetics of mission-critical compounds, like trichloroethylene and halon replacement chemicals. His work pioneering the military’s first large-scale investigation of human metabolic variability earned him the Air Force Achievement medal. During his time at the Air Force, his Metabolism Section produced 15 peer-reviewed government technical reports. Following completion of active duty in 1998, he accepted a position in the EPA’s National Center for Environmental Assessment in Cincinnati, in the Division in which EPA’s Integrated Risk Information System (IRIS) originated and was maintained until 2000. 

While at the EPA, Dr. Lipscomb initially undertook toxicology and dose-response responsibilities on a project aimed at quantifying the negative health impact of drinking water disinfection byproducts in comparison to the positive health impact of avoiding microbially-induced disease. He was invited to join the the Division’s work in chemical mixtures, where he was the sole toxicologist contributing to EPA’s guidances on chemical mixtures and cumulative risk. These guidances were developed specifically for application at Superfund sites. Dr. Lipscomb also served as Chemical Manager for several IRIS assessments, and developed several Provisional Peer-Reviewed Toxicity Value (PPRTV) assessments specifically requested by the EPA’s Office of Land and Emergency Response. Following an internal transfer to the EPA’s National Homeland Security Research Center (NHSRC), Dr. Lipscomb assumed overall responsibility for its Provisional Advisory Levels (PALs) program, initiated in 2004. Dr. Lipscomb was responsible for the development of acute and short-term exposure guidance values for oral and inhalation exposures to hazardous substances and chemical warfare agents. He developed and lectured in several continuing education courses taught locally, regionally, nationally and internationally on topics of toxicology and health risk assessment. During his time at the EPA, Dr. Lipscomb authored or co-authored 25 peer-reviewed government technical reports. 

Dr. Lipscomb holds certification in general toxicology as a Diplomate of the American Board of Toxicology. His contributions to the field of toxicology led to his recognition as a Fellow of the Academy of Toxicological Sciences in 2008. Dr. Lipscomb serves on the Health Advisory Board for NSF International, an organization which certifies devices, appliances, and equipment-contacting drinking water. He also serves on AIHA’s Emergency Response Planning Committee. He is a past president of the Ohio chapter of the Society for Risk Analysis and the Society of Toxicology, has served on Council for the Society of Toxicology, and is a past president of the American Board of Toxicology. He is on the editorial board and is a former Associate Editor for Toxicological Sciences and is an Associate Editor for Toxicology Mechanisms and Methods and Toxicology Reports. Dr. Lipscomb maintains an Adjuct Professorship in the Department of Pharmacology and Toxicology at the University of Louisville, where he is course director for a graduate level course, Introduction to Health Risk Assessment. 

Education

  • B.S. Biology, 1984 University of Central Arkansas Conway, AR
  • M.S. Biology, 1986 University of Central Arkansas Conway, AR
  • Ph.D., Interdisciplinary Toxicology University of Arkansas for Medical Sciences Little Rock, AR

Professional Affiliations

  • Society of Toxicology – Full Member
  • Society of Toxicology – Risk Assessment Specialty Section
  • Society of Toxicology – Mixtures Specialty Section
  • Society for Risk Analysis
  • Society for Risk Analysis – Dose Response Specialty Group
  • Society for Risk Analysis – Security and Defense Specialty Group
  • American Industrial Hygiene Association
  • American Industrial Hygiene Association – Emergency Response Planning Committee

Registrations and Certifications

  • Diplomate, American Board of Toxicology (DABT)
  • Fellow, Academy of Toxicological Sciences

(501)801-8500


Publications

  • Lipscomb JC. 2019. Purpose driven risk assessment. Toxicol Pathol (e-pub ahead of print, DOI: 10.1177/0192623319875714).
  • Kenyon EM, Lipscomb JC, Pegram RA, George BJ, Hines RN. 2019. The Impact of Scaling Factor Variability on Risk-Relevant Pharmacokinetic Outcomes in Children: A Case Study Using Bromodichloromethane (BDCM). Toxicol Sci 167:347–359.
  • Lipscomb JC. Application of quantitative dose response data in risk assessment and the incorporation of high throughput data, pp 559-572. In: Handbook of Developmental Neurotoxicology (Slikker, Paule, Cheng, eds.) Academic Press, New York, 2018.
  • Juberg DR, Knudsen TB, Sander M, Beck NB, Faustman EM, Mendrick DL, Fowle JR, Hartung T, Tice RR, Lemazurier E, Becker RA, Fitzpatrick SC, Daston GP, Harrill A, Hines RM, Keller DA, Lipscomb JC, Watson D, Bahadori T, Crofton KM. FutureTox III: Bridges for Translation. Toxicol Sci 155:22-13, 2017.
  • Kenyon EM, Eklund C, Lipscomb JC and Pegram RA. 2016. The impact of variation in scaling factors on the estimation of internal dose metrics: a case study using bromodichloromethane (BDCM). Toxicol Mech Methods 26:620-626.
  • Meek, ME and Lipscomb JC. 2015. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment. Toxicology 332:112-123.
  • Bale, AS, Kenyon, E, Flynn, TJ, Lipscomb, JC, Mendrick, DL, Hartung, T and Patton GW. 2014. Correlating In Vitro Data to In Vivo Findings for Risk Assessment. ALTEX 31:79-90.
  • Chiu, WA, Jinot, J, Scott, CS, Makris, SL, Cooper, GS, Dzubow, RC, Bale, AS, Evans, MV, Guyton, KZ, Keshava, N, Lipscomb, JC, Barone, Jr. S, Fox, JF, Gwinn, MR, Schaum, J and Caldwell, JC. 2013. Assessment Report: Key Findings and Scientific Issues in the Human Health Effects of Trichloroethylene. Environ Health Perspect, 121:303-311.
  • Lipscomb, JC, Maples-Reynolds, N, Mumtaz, M. Multiple Chemical Exposures and Risk Assessment. In: Computational Toxicology (B. Fowler, Ed). Elsevier, New York, New York, 2013.
  • Meek, ME, Barton, HA, Bessems, JG, Lipscomb, JC and Krishnan, K. 2013. Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment. Regul Toxicol Pharmacol 66:116–129.
  • Sasso, AF, Schlosser, PM, Kedderis, GL, Genter, M, Snawder, JE, Li, Z, Rieth, S and Lipscomb, JC. 2013. Application of an Updated Physiologically-Based Pharmacokinetic Model for Chloroform to Evaluate CYP2E1-Mediated Renal Toxicity in Rats and Mice. Toxicol Sci 131:360-374.
  • Kaiser, JP, Lipscomb, JC and Wesselkamper, SC. 2012. Putative mechanisms of Environmental Chemical-Induced Steatosis. Int. J. Toxicol. 31:551-563.
  • Lipscomb, JC, Haddad, S, Poet, T, and Krishnan, K. Physiologically Based Pharmacokinetic (PBPK) Models in Toxicity Testing and Risk Assessment. In: New Technologies for Toxicity Testing, (M Balls, RD Combes, N Bhogal, eds.). Landes Bioscience and Springer Science+Business Media, Boston, MA, 2012.
  • Colman, J, Rice, GE, Wright, M, Hunter, ES III, Teuschler, LK, Lipscomb, JC, Hertzberg, RC, Simmons, JE, Fransen, M, Osier, M, and Narotsky, MG. 2011. Identification of developmentally toxic drinking water disinfection byproducts and evaluation of data relevant to mode of action. Toxicol Appl Pharmacol 254:100–126.
  • Lambert, JC, Teuschler, LK, Rice, GE, Wright, JM, and Lipscomb, JC. Cumulative Environmental Risk In: Nriagu JO (ed.) Enc. of Environmental Health, volume 1, pp. 852–859 Burlington: Elsevier, 2011.
  • Mazur, CS, Kenneke, JF, Hess-Wilson, JK and Lipscomb, JC. 2010. Differences Between Human and Rat Intestinal and Hepatic Bisphenol-A Glucuronidation and the Influence of Alamethicin on In vitro Kinetic Measurements. Drug Metab Dispos. 38:2232-2238.
  • Lipscomb, JC, Lambert, JC and Teuschler, LK. Chemical Mixtures and Cumulative Risk Assessment, 253-281. in: Principles and Practice of Mixtures Toxicology (M. Mumtaz., ed.), Wiley, 2010.
  • Krishnan, K, Loizou, GD, Spendiff, M, Lipscomb, JC and Andersen, ME. PBPK Modeling: A Primer. In: Quantitative Modeling in Toxicology (K. Krishnan and M. Andersen, eds), Wiley, 2010.
  • Barter, ZE, Chowdry, JE, Harlow, JR, Snawder, JE, Lipscomb, JC, Rostami-Hodjegan A. 2008. Co variation of human microsomal protein per gram of liver with age: Absence of influence of operator and sample storage may justify inter laboratory data pooling. Drug Metab Dispos. 36:2405-2409.
  • Hays, SM, Aylward, LL, LaKind, JS, Bartels, MJ, Barton, HA, Boogaard, P, Brunk, C, DiZio, S, Dourson, M, Goldstein, DA, Lipscomb, J, Kilpatrick, ME, Krewski, D, Krishnan, K, Nordberg, M, Okino, M, Tan, Y-M, Viau, C and Yager, JW. 2008. Guidelines for the Derivation of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol S1:S4-S15.
  • LaKind, JS, Aylward, LL, Brunk, C, DiZio, S, Dourson, M, Goldstein, DE, Kilpatrick, ME, Krewski, D, Bartels, M, Barton, H, Boogaard, P, Lipscomb, J, Krishnan, K, Nordberg, M, Okino, M, Tan, C, Viau, C, Yager, JW and Hays ,SM. 2008. Guidelines for the Communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol S16-S26.
  • Lipscomb, JC and Poet, TS. 2008. In Vitro Measurements of Metabolism for Application in Pharmacokinetic Modeling. Pharmacology and Therapeutics. 118:82-103.
  • Lipscomb, JC, el Demerdash, E and Ahmed, AE. 2008. Haloacetonitriles: Metabolism and Toxicity. In Press, Reviews in Environmental Contamination and Toxicology.
  • Lipscomb, JC. Toxicokinetics for Drinking Water Risk Assessment. pp 91-122, In: Drinking Water Risk Assessment, B. Howd, ed., John Wiley and Sons, Hoboken, New Jersey. 2008.
  • Thompson, CM, Sonawane, B, Barton, HA, Dewoskin, RS, Lipscomb, JC, Chiu, WA, and Krishnan, KK. 2008. Approaches for Applications of Physiologically Based Pharmacokinetic Models in Risk Assessment. J Toxicol Envtl Health 11:1-29.
  • Barter, ZE, Bayliss, MK, Beaune, PH, Boobis, AR, Carlile, DJ, Edwards, RJ, Houston, JB, Lake, BG, Lipscomb, JC, Pelkonen, OR, Tucker, GT and Rostami-Hodjegan, A. 2007. Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Current Drug Metabolism. 8:33-45.
  • Chiu, WA, Chen, C, Hogan, K, Lipscomb, JC, Scott, CS and Subramaniam, R. 2007. High-to-low dose extrapolation: issues and approaches. Human Ecol Risk Assmt. 13: 46-52.
  • Chiu, WA, Barton, HA, Dewoskin, RS, Schlosser, P, Thompson, CM, Sonawane, B, Lipscomb, JC and Krishnan, K. 2007. Evaluation of Physiologically Based Pharmacokinetic Models for Use in Risk Assessment. J App Toxicol. 27:218-237.
  • DeWoskin, RS, Lipscomb, JC and Thompson, C. 2007. Pharmacokinetic and Physiologically Based Pharmacokinetic Models in IRIS assessments. In: Lipscomb JC and Ohanian EV (eds), Toxicokinetics and Risk Assessment. Informa Healthcare Publishers, New York, NY.
  • Lambert, JC and Lipscomb, JC 2007. Mode of Action as a Determining Factor in Human Health Risk Assessment of Chemical Mixtures. Regul Toxicol Pharmacol. 49:183-194.
  • Lipscomb, JC, Lambert, JC, and Mumtaz, M. The Toxicity and Risk of Chemical Mixtures. In: Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals (S. Ekins, Ed) John Wiley & Sons, New York. 2007.
  • Mahle, DA, Gearhart, JM, Grigsby, C, Mattie, DR, Barton, HA, Lipscomb, JC, and Cook, RS. 2007. Age-Dependent Partition Coefficients for a Mixture of Volatile Organic Solvents in Sprague-Dawley Rats and Humans. J Toxicol Envtl Health 70:1745-1751.
  • Mazur, CS, Kenneke, JF, Tebes-Stevens, C, Okino, MS, Lipscomb, JC. 2007. In Vitro Metabolism of the Fungicide and Environmental Contaminant Trans-Bromuconazole and Implications for Risk Assessment. J Toxicol Envtl Health. 70: 1241–1250.
  • Robinson, PJ, Gearhart, JM, Mahle, DA, Merrill, EA, Sterner, TR, Lipscomb, JC, and Yu, KO. 2007. Considerations of Design and Data when Developing Physiologically-Based Pharmacokinetic Models In: Lipscomb JC and Ohanian EV (eds), Toxicokinetics and Risk Assessment. Informa Healthcare Publishers, New York, NY.
  • Rodriguez, CE, Mahle, DA, Gearhart, JM, Mattie, DR, Lipscomb, JC, Cook, RS and Barton, HA. 2007. Predicting Age-Dependent Pharmacokinetics of Six Volatile Organic Compounds in the Rat Utilizing Physiologically-Based Pharmacokinetic Modeling. Toxicol Sci. 98:43-56.
  • Asorey, CM, Muñoz, LM, Pérez-Coll, CS, Lipscomb, JC and Herkovits, J. Efecto Del Ácido Dicloroacético Sobre La Toxicidad Del Cobre Y El Arsénico En Embriones De Anfibio (Effect Of Dicloroacétic Acid On The Toxicity Of Copper And Arsenic In Amphibian Embryos). In: Salud Ambiental y Humana: Una Vision Holistica (Environmental and Human Health: A Holistic Vision). SETAC ISBN - 10: 987-05-1959-8. Ed. Jorge Herkovits pp. 94-96, 2006.
  • Chiu, WA, Okino, MS, Lipscomb, JC and Evans, MV. 2006. Issues in the Pharmacokinetics of Trichloroethylene and Its Metabolites. Env Health Perspec 114(9):1450-1456.
  • Herkovits, J, Muñoz, LM, Asorey, CM and Lipscomb, JC. Amphitox: Un Método Rápido Para Detectar La Toxicidad Remanente Al Proceso De Desinfección Del Agua De Red. (Amphitox: A Fast Method To Detect The Toxicity Of Disinfection Byproducts In Distributed Drinking Water). In: Salud Ambiental y Humana: Una Vision Holistica (Environmental and Human Health: A Holistic Vision). SETAC ISBN - 10: 987-05-1959-8. Ed. Jorge Herkovits pp. 34-36, 2006.
  • Beliveau, M, Lipscomb, J, Tardif, R and Krishnan, K. 2005. Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmacokinetics of organic chemicals. Chem Res Toxicol. 18:475-485.
  • Gentry, PR, Haber, LT, McDonald, TB, Zhao, Q, Covington, T, Nance, P, Clewell, HJ III, Lipscomb, JC and Barton, HA. 2005. Data for Physiologically-Based Pharmacokinetic Modeling in Neonatal Animals: Physiological Parameters in Mice and Sprague-Dawley Rats. J Child Health 2:363-411.
  • Teuschler, LK, Rice, GE, Wilkes, CR, Lipscomb, JC and Power, F.W. 2004. A Feasibility Study of Cumulative Risk Assessment Methods for Drinking Water Disinfection By-Product Mixtures. J Toxicol Envtl Health (Part A). 67:755-777.
  • Lipscomb, JC, Meek, ME, Krishnan, K, Kedderis, GL, Clewell, H and Haber, LT. 2004. Incorporation of Pharmacokinetic and Pharmacodynamic Data into Risk Assessments. Toxicol Mech Methods. 14: 145-158.
  • Lipscomb, JC, Barton, H, Tornero-Velez, R, Evans, MV, Alcasey, S, Snawder, JE, and Laskey, J. 2004. The Metabolic Rate Constants and Specific Activity of Human and Rat Cytochrome P450 2E1 Toward Chloroform. J Toxicol Envtl Hlth (Part A). 67:537-553.
  • Lipscomb, JC. 2004. Evaluating the Relationship between Variance in Enzyme Expression and Toxicant Concentration in Health Risk Assessment Human Ecol Risk Asses. 10:39-55.
  • Moudgal, CJ, Venkatapathy, R, Choudhury, H, Bruce, RM and Lipscomb, JC. 2003. Application of QSTRs in the Selection of a Surrogate Toxicity Value for a Chemical of Concern. Env Sci Tech 37:5228-5235.
  • Kedderis, GL and Lipscomb, JC. 2003. Application of in Vitro Biotransformation Data and Pharmacokinetic Modeling to Risk Assessment Toxicol Ind Hlth 17:315-321.
  • Lipscomb, JC. 2003. How Differences in Enzyme Expression Can Translate into Pharmacokinetic Variance and Susceptibility to Risk. J. Child. Health 1:189-202.
  • Lipscomb, JC, Teuschler, LK, Swartout, JC, Striley, CAF and Snawder, JE. 2003. Variance of Microsomal Protein and Cytochrome P450 2E1 and 3A Forms in Adult Human Liver. Toxicol Mech Methods. 13:45-51.
  • Lipscomb, JC, Teuschler, LK, Swartout, J, Popken, D, Cox, T and Kedderis, GL. 2003. The Impact of Cytochrome P450 2E1-dependent Metabolic Variance on a Risk Relevant Pharmacokinetic Outcome in Humans. Risk Analysis 23:1221-1238.
  • Donohue, JM and Lipscomb, JC. 2002. Health Advisory Values for Drinking Water Contaminants and the Methodology for Determining Acute Exposure Values. Sci. Tot. Environ. 288:43-49.
  • Fisher, RL, Hasal, SJ, Lipscomb, JC, Gandolfi, AJ and Brendel, K. 2002. Cold and Cryopreservation of Monkey Liver Slices. Toxicol Mech Methods. 12:119-133.
  • Lipscomb, JC and Kedderis, GL. 2002. Incorporating Human Interindividual Biotransformation Variance in Health Risk Assessment. Sci. Tot. Environ. 288:13-21.
  • Byczkowski, JZ and Lipscomb, JC. 2001. Physiologically Based Pharmacokinetic Modeling of the Lactational Transfer of Methylmercury. Risk Anal.21:869-882.
  • Rice, G, Teuschler, LK, Moudgal, C, Bruce, B, Murphy, P, Lipscomb, JC, Miltner, RJ, Richardson, S, Clark, RM and Cohen, J. Risk Assessment of Complex Mixtures of Disinfection Byproducts (DBPs): Methods for Considering Unidentified DBPs. In: Microbial Pathogens and Disinfection By-products in Drinking Water: Health Effects and Management of Risks. Eds. GF Craun, FS Hauchman, DE Robinson. ILSI Press. Washington, D.C. pp. 571-580, 2001.
  • Rice, G, Murphy, PA, Teuschler, LK, Lipscomb, JC, Boutin, BK, Brown, ME, Clark, RM, Rheingans, RD and Cohen, J. U.S. EPA’s Comparative Risk Assessment. In: Microbial Pathogens and Disinfection By-products in Drinking Water: Health Effects and Management of Risks. Eds. GF Craun, FS Hauchman, DE Robinson. ILSI Press. Washington, D.C. pp. 371-394, 2001.
  • Lash, LH, Fisher, JW, Lipscomb, JC and Parker, JC. 2000. Metabolism of Trichloroethylene. Environ Health Perspec 108 (Supl 2): 177-200.
  • Lipscomb, JC, Byczkowski, JZ and Harvey, T. Physiologically Based Pharmacokinetic Modeling of the Lactational Transfer of Methylmercury. Proceedings of the Sixth International Symposium on Metal Ions in Biology and Medicine, San Juan, Puerto Rico, USA, May 7-10, 2000, (J. Centeno, P. Collery, G. Vernet, et al., eds.), John Libbey Eurotext, Paris, 2000.
  • Moudgal, CJ, Lipscomb, JC and Bruce, RM. 2000. Potential Health Effects of Drinking Water Disinfection Byproducts Using Quantitative Structure Toxicity Relationship. Toxicology 147:109-131.
  • Murphy, P, Rice, G, Teuschler, L, Boutin, B, Brown, M, Clark, R, Cohen, J, Harvey, T, Lipscomb, J, Miltner, R, Papa, L and Rheingans, R. 2000. A Comparative Risk Assessment Methodology to Assess Drinking Water Treatment Technologies. Proceedings of the 6th National Drinking Water and Waste Water Treatment Technology Transfer Workshop. Kansas City, MO, August 2-4, 1999. (Online at: http://www.epa.gov/region07/programs/wwpd/workshop99/region7workshop_comparative_ra.pdf).
  • Snawder, JE and Lipscomb, JC. 2000. Interindividual Variance of Cytochrome P450 Forms in Human Hepatic Microsomes: Correlation of Individual Forms with Xenobiotic Metabolism and Implications in Risk Assessment. Regul. Toxicol. Pharmacol. 32:200-209.
  • Teuschler, LK, Gennings, C, Stiteler, WM, Hertzberg, RC, Colman, JT, Thiyagarajah, A, Lipscomb, JC, Hartley, WR and Simmons, JE. 2000. A Multiple-Purpose Design Approach to the Evaluation of Risks from Complex Mixtures of Disinfection By Products (DBPs). Drug Chem Toxicol. 23(1):307-321.
  • Teuschler, LK, Rice, G, Lipscomb, JC and Swartout, J. 2000. Extrapolation Issues in Human Health Risk Assessment: Methods for Potential Use in Sex-Specific Health Evaluations. Proceedings of the Annual Meeting of the American Statistical Association. Indianapolis, IN. Aug. 13-17, 2000. American Statistical Association. pp. 50-59.
  • Courson, DL, Mattie, DR, English, JH, Lipscomb, JC. 1999. Identifying Potential Human Health Risks of Combustion Byproducts from Aerospace Advanced Composite Materials. Proceedings of the Smoke/Obscurants Symposium XX, US Army, Edgewood Arsenal, MD. ERDEC-CR-270 (STCTR3192), pp. 195- 202.
  • Lipscomb, JC and Confer, PD. Human Hepatocytes, A Novel Animal Alternative. In: Toxicity Assessment Alternatives: Methods, Issues, Opportunities (H. Salem and S.A. Katz, eds.), Humana Press, Totowa, NJ, pp. 227-240, 1999.
  • Lash, LH, Lipscomb, JC, Putt, DA and Parker, JC. 1999. Glutathione Conjugation of Trichloroethylene in Human Liver and Kidney: Kinetics and Individual Variation. Drug Metab Dispos 27:351-359.
  • Griffin, JM, Lipscomb, JC and Pumford, NR. 1998. Covalent Binding of Trichloroethylene to Proteins in Human and Rat Hepatocytes. Tox Lett 95:173-81.
  • Lipscomb, JC and Garrett, CM. 1998. Effect of Organ Procurement Conditions on Cytochrome P-450 Activity in Rat Liver Microsomes. In Vitro Mol Toxicol 11:265-270.
  • Lipscomb, JC, Fisher, JW, Confer, PD and Byczkowski, JZ. 1998. In Vitro to in Vivo Extrapolation for Trichloroethylene Metabolism in Humans. Toxicol Appl Pharmacol 152:376-387.
  • Lipscomb, JC, Confer, PD, Miller, MR, Stamm, SC, Snawder, JE and Bandiera, SM. 1998. Metabolism of Trichloroethylene and Chloral Hydrate by the Japanese Medaka in vitro. Environ Toxicol Chem 17:325-332.
  • Lipscomb, JC, Garrett, CM and Snawder, J. 1998. Use of Kinetic and Mechanistic Data in Species Extrapolation of Bioactivation: Cytochrome P-450 Dependent Trichloroethylene Metabolism at Occupationally Relevant Concentrations. J Occup Health 40:110-117.
  • Lipscomb, JC, Buttler, GW and Confer, PD. 1997. Chloral Hydrate Formation in the Japanese Medaka Minnow. Annals Clin Lab Sci 27:158-163.
  • Lipscomb, JC, Garrett, CM, and Snawder, JE. 1997. Cytochrome P450-dependent Metabolism of Trichloroethylene: Interindividual Differences in Humans. Toxicol Appl Pharmacol, 142:311-318.
  • Lipscomb, JC, Kuhlmann, KJ, Cline, JM, Larcom, BJ, Peterson, RD and Courson, DL. 1997. Combustion Products from Advanced Composite Materials. Drug Chem Toxicol 20:281-192.
  • Moghaddam, AP, Abbas, R, Fisher, JW and Lipscomb, JC. 1997. Role of Mouse Intestinal Microflora in Dichloroacetic Acid Formation, an in vivo Study. Human Exptl Toxicology 16:629-635.
  • Barton, HA, Flemming, CD and Lipscomb, JC. 1996. Evaluating Human Variability in Chemical Risk Assessment: Hazard Identification and Dose-Response Assessment for Noncancer Oral Toxicity of Trichloroethylene. Toxicology, 110:271-287.
  • Channel, S, Dodd, D, Fisher, J, George, M, Lipscomb, J, McDougal, J, Vinegar, A and Williams, J. Supporting Documentation for the Exposure Guidance Levels for Hydrofluorocarbon-123. In: Toxicity Alternatives to Chlorofluorocarbons: HFC-134a and HCFC-123, Committee on Toxicology, National Research Council, National Academy Press, Washington, D.C. (1996).
  • Lipscomb, JC, Mahle, DA, Brashear, WT and Garrett, CM. 1996. A Species Comparison of Chloral Hydrate Metabolism in Blood and Liver. Biochem Biophys Res Commun 227(2):340-350.
  • Moghaddam, AP, Abbas, RR, Fisher, JW, Stavrou, S and Lipscomb, JC. 1996. Formation of Dichloroacetic Acid by Rat and Mouse Gut Microflora, an in vitro Study. Biochem Biophys Res Commun 228:639-645.
  • Witzmann, F, Coughtrie, MWH, Fultz, C and Lipscomb, J. 1996. Effect of Structurally Diverse Peroxisomal Proliferators on Rat Hepatic Sulfotransferase. Chem Biol Interact 99:73-84.
  • Witzmann, FA, Fultz, CD and Lipscomb, JC. 1996. Toxicant-induced Alterations in Two-Dimensional Electrophoretic Patterns of Hepatic and Renal Stress Proteins. 17:198-202.
  • Lipscomb, JC, Mahle, DA, Brashear, WT and Barton, HA. 1995. Dichloroacetic Acid: Metabolism in Cytosol. Drug Metab Dispos 23:1202-1205.
  • Witzmann, F, Fultz, C and Lipscomb, J. 1995. Comparative 2D-Electrophoretic Mapping of Human and Rodent Hepatic Stress Proteins as Potential Biomarkers. Applied and Theoretical Electrophoresis, 5:113-117.
  • Jarabek, AM, Fisher, JW, Rubenstein, R, Lipscomb, JC, Williams, RJ, Vinegar A, and McDougal, JN. 1994. Mechanistic Insights Aid the Search for CFC Substitutes: Risk Assessment of HCFC-123 as an Example. Risk Analysis 14(3):231-250.
  • Scallet, AC, Slikker, W, Jr, Holson, R., Lipe, GW, Lipscomb, JC, Rountree, RL, Stewart, CW and Matthews, JC, 1992. Age and Dietary Factors in Hippocampal Sensitivity to Trimethyltin. Ann. N.Y. Acad. Sci. 648:340-342.
  • Leakey, JEA, Cunny, HC, Bazare, J, Webb, P, Lipscomb, JC, Slikker, W, Jr. Feuers, RJ, Duffy, PH and Hart, RW, 1989. Effects of Aging and Caloric Restriction on Hepatic Drug Metabolizing Enzymes in the Fischer 344 Rat. II: Effects on Conjugating Enzymes. Mech. Age. Devel. 48:157-166.
  • Lipscomb, JC, Paule, MG, and Slikker, W, Jr., 1989. The Disposition of 14C-Trimethyltin in the Pregnant Rat and Fetus. Neurotoxicol. Teratol. 11:185-191.
  • Lipscomb, JC, Paule, MG, and Slikker, W, Jr, 1986. Fetomaternal Kinetics of Trimethyltin. Neurotoxicology 7(2):581-590.
  • Slikker, W, Jr, Ali, SF, Lipscomb, JC and Denton, R, 1985. Time-Course Alterations in the Tremor and Muscarinic Receptor Binding Produced by Trimethyltin. Proc. West. Pharmacol. Soc. 28:139-142.

As Featured In

  • Arkansas Democrat-Gazette
  • Arkansas Business
cteh logo
Employee Login

About

  • About Us
  • Our Team
  • Publications

Solutions

  • Readiness
  • Response
  • Recovery

Services

  • Emergency Response
  • Environmental Response
  • Epidemiology
  • Expert Services
  • Industrial Hygiene
  • Occupational Health
  • Pandemic Services
  • Response Management
  • Risk Assessment
  • Safety
  • Technology
  • Toxicology
  • Training

Markets

  • Chemicals
  • Government & Public Sector
  • Manufacturing
  • Maritime
  • Petroleum
  • Pipeline
  • Power and Utilities
  • Transportation

Software

  • CarbonCM
  • Carbon Stories

Careers

  • Culture
  • Opportunities

Blog

  • View Blog

Contact

5120 Northshore Drive
North Little Rock, AR 72118
Ph: 501.801.8500
Media

Emergency Response

24-Hour Help Desk

1.866.869.2834
  • 2023 CTEH. All Rights Reserved.
  • Terms & Conditions
  • Privacy Notice
  • Designed by: The Old State, a Dallas Web Design Agency



By clicking “Accept” or continuing to use this site, you agree to the use of cookies, as described in our Privacy Notice and Cookie Notice, where and as permitted by law.

Accept